The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 11128646 |
69 |
Synthesis and biological evaluation of 2,5-dihydropyrazol. |
RhôNe-Poulenc Rorer |
| 24785301 |
83 |
Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD. |
Astrazeneca |
| 9873708 |
16 |
N-arylrolipram derivatives as potent and selective PDE4 inhibitors. |
Novartis Horsham Research Center |
| 10691693 |
64 |
Palladium-catalyzed cross-coupling reactions for the synthesis of 6, 8-disubstituted 1,7-naphthyridines: a novel class of potent and selective phosphodiesterase type 4D inhibitors. |
Novartis Pharma |
| 11844693 |
35 |
Synthesis and biological evaluation of imidazol-2-one and 2-cyanoiminoimidazole derivatives: novel series of PDE4 inhibitors. |
Janssen-Cilag |
| 12161123 |
13 |
A prenylated flavonol, sophoflavescenol: a potent and selective inhibitor of cGMP phosphodiesterase 5. |
Korea Institute Of Science & Technology |
| 15125967 |
30 |
Identification of purine inhibitors of phosphodiesterase 7 (PDE7). |
Bristol-Myers Squibb Pharmaceutical Research Institute |
| 9873643 |
75 |
Quinazolines: combined type 3 and 4 phosphodiesterase inhibitors. |
Novartis Pharma |
Search and Browse
